4//SEC Filing
Sorrento Therapeutics, Inc. 4
Accession 0001209191-14-058994
CIK 0000850261operating
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:00 PM ET
Size
5.5 KB
Accession
0001209191-14-058994
Insider Transaction Report
Form 4
Durand Mark
Director
Transactions
- Award
Stock Options
2014-09-18+12,000→ 25,000 totalExercise: $4.78Exp: 2024-09-18→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]1/15 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the reporting person's continued service on the issuer's board of directors on each such date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850261
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:00 PM ET
- Size
- 5.5 KB